The molecular controls governing commitment of hematopoietic stem cells to specific lineages have still not been fully elucidated. The importance of understanding such controls is underscored by the fact that a block in differentiation is a hallmark of acute leukemias. Acute myeloid leukemia (AML), involving the precursors of myeloid cells (granulocytes and monocytes/macrophages), accounts for over 90 percent of acute leukemias in adults. In this application, I propose to continue our study of the molecular basis of differentiation of myeloid cells, employing a detailed analysis of the transcription factor PU.1, which regulates nearly every myeloid gene, and is absolutely required for normal myeloid development. PU.1 is expressed in stem cells and upregulated early during myeloid and lymphoid commitment. The importance of understanding how PU.1 is regulated is underscored by studies indicating that altered expression of PU. 1 can induce changes in hematopoietic lineage development, and in some experimental cases misexpression leads to leukemia. Thus, the overall goal of this continuation proposal is to continue our studies of how PU.1 is regulated, and what its function is in adult hematopoiesis. These studies will further our understanding of (1) commitment of normal hematopoietic precursors to the myeloid lineage; and (2) the block in normal myeloid maturation from blasts to mature myeloid cells in AML. Therefore, the Specific Aims are: (1)To determine how PU.1 expression is regulated in hematopoietic cells, using transgenic and knockout studies; (2) To determine the role of PU.1 in adult hematopoiesis by studying a conditional knockout model; and (3) To determine whether different levels of PU. 1 expression play a role in directing hematopoietic lineage determination and development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA041456-19
Application #
6722302
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Mufson, R Allan
Project Start
1986-01-01
Project End
2008-12-31
Budget Start
2004-02-07
Budget End
2004-12-31
Support Year
19
Fiscal Year
2004
Total Cost
$432,961
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Welner, Robert S; Bararia, Deepak; Amabile, Giovanni et al. (2013) C/EBP? is required for development of dendritic cell progenitors. Blood 121:4073-81
Ye, Min; Zhang, Hong; Amabile, Giovanni et al. (2013) C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol 15:385-94
Staber, Philipp B; Zhang, Pu; Ye, Min et al. (2013) Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells. Mol Cell 49:934-46
Zhang, Yue; Yan, Xiaomei; Sashida, Goro et al. (2012) Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Blood 120:1118-29
Leddin, Mathias; Perrod, Chiara; Hoogenkamp, Maarten et al. (2011) Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 117:2827-38
Huang, Gang; Zhao, Xinghui; Wang, Lan et al. (2011) The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Blood 118:6544-52
Levantini, Elena; Lee, Sanghoon; Radomska, Hanna S et al. (2011) RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element. EMBO J 30:4059-70
Aikawa, Yukiko; Katsumoto, Takuo; Zhang, Pu et al. (2010) PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med 16:580-5, 1p following 585
Hoogenkamp, Maarten; Lichtinger, Monika; Krysinska, Hanna et al. (2009) Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 114:299-309
Ueno, S; Tatetsu, H; Hata, H et al. (2009) PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL. Oncogene 28:4116-25

Showing the most recent 10 out of 73 publications